Search hospitals > Massachusetts > Methuen
Dana Farber-Merrimack Valley
Claim this profileMethuen, Massachusetts 01844
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Lung Cancer
Conducts research for Breast cancer
Conducts research for Breast Cancer
Conducts research for Parotid Gland Cancer
11 reported clinical trials
2 medical researchers
Summary
Dana Farber-Merrimack Valley is a medical facility located in Methuen, Massachusetts. This center is recognized for care of Non-Small Cell Lung Cancer, Lung Cancer, Breast cancer, Breast Cancer, Parotid Gland Cancer and other specialties. Dana Farber-Merrimack Valley is involved with conducting 11 clinical trials across 21 conditions. There are 2 research doctors associated with this hospital, such as Pedro M. Sanz-Altamira and Taylor M. Ortiz.Area of expertise
1Non-Small Cell Lung Cancer
Stage III
Stage II
Stage I
2Lung Cancer
Stage III
Stage II
Stage I
Top PIs
Pedro M. Sanz-AltamiraDana Farber-Merrimack Valley2 years of reported clinical research
Studies Breast Cancer
Studies Lung Cancer
18 reported clinical trials
38 drugs studied
Taylor M. OrtizFranciscan Health Indianapolis1 year of reported clinical research
Studies Breast Cancer
Studies Solid Malignant Tumor
8 reported clinical trials
22 drugs studied
Clinical Trials running at Dana Farber-Merrimack Valley
Lung Cancer
Non-Small Cell Lung Cancer
Esophageal cancer
Rectal Cancer
Esophageal Cancer
Breast Cancer
Gastric Cancer
Esophageal Adenocarcinoma
Gastric cancer
Gastroesophageal Junction Adenocarcinoma
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting2 awards Phase 3
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Dana Farber-Merrimack Valley?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.